Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plovamer Acetate vs Copaxone in RRMS
NCT01963611Phase 2Terminated
- Sponsor
- EMD Serono
- Start
- Oct 2013
- Primary completion
- Mar 2015
- Countries
- 17
01
Overview
Phase 2, randomised, single-blind trial of plovamer acetate in multiple sclerosis (MS) (5 arms), sponsored by EMD Serono. Primary endpoint: Mean Number of Time Constant 1 (T1) Gadolinium (Gd)-Enhancing Lesions Per Subject and Scan at 40 weeks. Started Oct 2013; status: terminated.
02
Drugs
plovamer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01963611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963611.